About Agneta Breitenstein
Form D filings for MedArrive in 2023 list Agneta Breitenstein as director.
Agneta Breitenstein first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Agneta Breitenstein in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Agneta Breitenstein works with at each company, as listed on that company's latest Form D.
MedArrive Inc. · Form D, Apr 11, 2023
IP
Inna Plumb
Executive officer
WS
William Sullivan
Director
AC
Annie Case
Director
DT
Daniel Trigub
CEO and director
AH
Andy Harrison
Director